These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26539643)

  • 1. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
    de Freitas Junior JC; Morgado-Díaz JA
    Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-glycomic profiling of colorectal cancer according to tumor stage and location.
    Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
    PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
    Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
    Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.
    Kizuka Y; Taniguchi N
    Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
    Sethi MK; Fanayan S
    Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of N-glycans expressed in tumor tissues with those expressed in adjacent non-tumor tissues of colorectal cancer patients
.
    Ji E
    Int J Clin Pharmacol Ther; 2019 May; 57(5):249-258. PubMed ID: 30738496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
    Taniguchi N; Kizuka Y
    Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched N-glycans regulate the biological functions of integrins and cadherins.
    Zhao Y; Sato Y; Isaji T; Fukuda T; Matsumoto A; Miyoshi E; Gu J; Taniguchi N
    FEBS J; 2008 May; 275(9):1939-48. PubMed ID: 18384383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-glycan regulation of apoptosis and proliferation in colorectal cancer cell lines.
    Patsos G; Robbe-Masselot C; Klein A; Hebbe-Viton V; Martin RS; Masselot D; Graessmann M; Paraskeva C; Gallagher T; Corfield A
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1372-4. PubMed ID: 17956354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
    Carvalho S; Reis CA; Pinho SS
    Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
    Mereiter S; Balmaña M; Campos D; Gomes J; Reis CA
    Cancer Cell; 2019 Jul; 36(1):6-16. PubMed ID: 31287993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
    Guo H; Abbott KL
    Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
    Liu S; Cheng L; Fu Y; Liu BF; Liu X
    J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
    Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin microarray based glycan profiling of exosomes for dynamic monitoring of colorectal cancer progression.
    Sun X; Chen B; Shan Y; Jian M; Wang Z
    Anal Chim Acta; 2024 Aug; 1316():342819. PubMed ID: 38969421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation characteristics of colorectal cancer.
    Holst S; Wuhrer M; Rombouts Y
    Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines.
    Sethi MK; Thaysen-Andersen M; Smith JT; Baker MS; Packer NH; Hancock WS; Fanayan S
    J Proteome Res; 2014 Jan; 13(1):277-88. PubMed ID: 24295106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program.
    Wang D; Madunić K; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
    Mol Cell Proteomics; 2024 Jun; 23(6):100776. PubMed ID: 38670309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to the madness of N-glycan complexity?
    Stanley P
    Cell; 2007 Apr; 129(1):27-9. PubMed ID: 17418781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.